nplooj ntawv_banner

khoom

Chaw tsim tshuaj Fasoracetam hmoov CAS No.: 110958-19-5 99% purity min. rau cov khoom xyaw ntxiv

Kev Piav Qhia Luv:

Cov tshuaj Fasoracetam yog ib hom tshuaj tsim los ntawm ib chav kawm ntawm cov tshuaj hu ua dihydropyridine pyrrolidone chav kawm.


Cov Khoom Qhia Txog Khoom

Cov Cim Npe Khoom

Cov Yeeb Yaj Kiab Txog Khoom

Cov Khoom Siv

Lub npe khoom

Fasoracetam

Lwm lub npe

FASORACETAM;

(5R)-5-(piperidine-1-carbonyl)-2-pyrrolidone;

(5R)-5-(piperidine-1-carbonyl)pyrrolidin-2-ib;

(5R)-5-piperidin-1-ylcarbonylpyrrolidin-2-ib

CAS Nr.

110958-19-5

Cov mis molecular

C10H16N2O2

Qhov hnyav ntawm cov molecule

196.25

Kev dawb huv

99.0%

Qhov tsos

Dawb crystalline hmoov

Ntim khoom

1 kg/hnab 25 kg/nruas

Daim Ntawv Thov

Nootropic

Kev taw qhia txog khoom

Fasoracetam, yog ib qho nootropic compound thawj zaug tsim nyob rau hauv Nyiv. Nws sib koom ua ke zoo sib xws nrog lwm cov racemates xws li piracetam, tab sis qhia txog cov yam ntxwv tshwj xeeb. Fasoracetam xav tias yuav hloov cov teebmeem ntawm ntau yam neurotransmitters hauv lub hlwb, suav nrog GABA, glutamatergic, thiab cholinergic systems. Los ntawm kev cuam tshuam rau kev tso tawm thiab kev nqus ntawm cov neurotransmitters no, fasoracetam yuav txhim kho kev ua haujlwm ntawm lub hlwb xws li kev mloog, kev nco, thiab kev ua cov ntaub ntawv. Kev tshawb fawb thiab cov pov thawj anecdotal qhia tias fasoracetam yuav muab ntau yam txiaj ntsig ntawm lub hlwb. Ib qho ntawm nws cov teebmeem tseem ceeb yog los txhim kho kev mloog thiab kev mloog, ua rau nws yog tus pab tau rau cov neeg uas raug kev txom nyem los ntawm kev tsis mloog lossis kev tsis mloog hyperactivity disorder (ADD / ADHD). Cov kev tshawb fawb ua ntej tau pom cov txiaj ntsig zoo, qhia txog fasoracetam lub peev xwm los txhim kho kev mloog, txo qhov kev xav tsis zoo thiab txhim kho kev tswj hwm kev paub. Tsis tas li ntawd, kev tshawb fawb tsiaj qhia tias Fasoracetam txhim kho lub zog mus sij hawm ntev, ib qho txheej txheem cuam tshuam nrog kev nco thiab synaptic plasticity.

Feature

(1) Kev huv siab: Fasoracetam tuaj yeem tau txais cov khoom huv siab los ntawm kev ua kom cov txheej txheem tsim khoom. Kev huv siab txhais tau tias muaj kev nyab xeeb zoo dua thiab tsawg dua cov kev tsis zoo.

(2) Kev Nyab Xeeb: Cov kev tshawb fawb tau qhia tias fasoracetam feem ntau yog qhov ua tau zoo thiab tsis muaj kev phiv loj heev thaum siv rau hauv cov koob tshuaj pom zoo.

(3) Kev Ruaj Ntseg: Fasoracetam muaj kev ruaj ntseg zoo thiab tuaj yeem tswj nws cov haujlwm thiab cov nyhuv hauv qab ntau qhov chaw thiab cov xwm txheej cia khoom.

Cov ntawv thov

Fasoracetam tau tshwm sim los ua ib qho tshuaj lom neeg uas muaj peev xwm txhim kho kev txawj ntse, tshwj xeeb tshaj yog kev nco, kev mloog zoo, thiab kev kawm, thiab siv tau ua ib qho khoom noj khoom haus ntxiv. Cov khoom no ua haujlwm ua ib qho kev txhim kho kev nco los ntawm kev txhawb nqa cov metabolic glutamate receptors. Hauv thaj chaw biological, Fasoracetam kuj tseem siv los ua ib qho kev xaiv inhibitor los kawm txog cov txheej txheem biological xws li cell signaling thiab apoptosis.


  • Yav dhau los:
  • Tom ntej no:

  • Sau koj cov lus ntawm no thiab xa tuaj rau peb